These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6952952)

  • 1. Response of acute myelomonocytic leukemia to alkyl-lysophospholipids. A case report.
    Berdel WE; Fink U; Maubach PA; Permanetter B; Rastetter J
    Blut; 1982 Mar; 44(3):177-86. PubMed ID: 6952952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
    Dulisch I; Neumann HA; Löhr GW; Andreesen R
    Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
    Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
    Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature dependence of leukemic cell destruction by alkyl-lysophospholipids (NSC 324368).
    Andreesen R; Modolell M; Oepke GH; Munder PG
    Exp Hematol; 1983 Jul; 11(6):564-70. PubMed ID: 6617791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG
    Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid.
    Andreesen R; Munder PG
    J Natl Cancer Inst; 1983 Apr; 70(4):623-7. PubMed ID: 6300501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562.
    Tidwell T; Guzman G; Vogler WR
    Blood; 1981 Apr; 57(4):794-7. PubMed ID: 6937218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity in the serum of a patient with metastasizing nephroblastoma given intravenous infusions of alkyl-lysophospholipids in a phase I study.
    Andreesen R; Arnold H; Löhr GW
    Blut; 1982 Feb; 44(2):79-82. PubMed ID: 6277413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
    Vogler WR; Somberg LB; Glasser L
    Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structural changes of cell membrane and cell differentiation induction].
    Honma Y
    Nihon Rinsho; 1985 Apr; 43(4):706-8. PubMed ID: 3861893
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
    Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR
    Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myelomonocytic leukemia: an unusual variant with both granulocytic and monocytic esterases in the leukemic cells.
    Li CY; Phyliky RL; Yam LT
    Mayo Clin Proc; 1986 Feb; 61(2):104-9. PubMed ID: 3456074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
    Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
    J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro differentiation of myeloblasts from a patient with acute myeloid leukemia.
    Kirshner J; Goldberg J
    Am J Clin Pathol; 1981 Apr; 75(4):617-21. PubMed ID: 6939329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of humoral regulators on proliferation and maturation of normal and leukemic cells.
    Karp JE; Burke PJ
    Cancer Res; 1976 May; 36(5):1674-9. PubMed ID: 1063598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chemotherapy on bone marrow stroma in mice with acute myelogenous leukemia. Correlation with CFU-C and CFU-D.
    Ben-Ishay Z; Prindull G; Sharon S; Borenstein A
    Leuk Res; 1985; 9(8):1059-67. PubMed ID: 3862923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early tumor and leukemia response to alkyllysophospholipids in a phase I study.
    Berdel WE; Schlehe H; Fink U; Emmerich B; Maubach PA; Emslander HP; Daum S; Rastetter J
    Cancer; 1982 Nov; 50(10):2011-5. PubMed ID: 7127246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
    Hiçsönmez G
    Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.